Q3 Revenue Hits $30.9M but Operating Loss Widens to $13M
OSUR sits 68% above its 52-week low of $2.08.
Summary
OraSure posted Q3 revenue of $30.9 million with a 45.2% gross margin, but operating losses remain heavy: $13 million on a GAAP basis and $10.2 million adjusted. The loss is the story here — the company has been shrinking, with Q1 2026 revenue down 7% year over year and losses widening, so Q3 shows the same pattern rather than a turn. This lands against an activist backdrop: Yorkville and Islet disclosed a joint 6.4% stake on September 18 and are pushing for board changes, including possible director replacements, which gives dissidents fresh ammunition on cost control. With a market cap near $243 million, a $13 million quarterly operating loss is a meaningful cash burn relative to the company's size. Watch for the full Q3 release and any management commentary on the buyback and restructuring progress.
At the time of this announcement, OSUR was trading at $3.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $243.5M. The 52-week trading range was $2.08 to $4.58. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.